Congrès annuel de la Société Suisse de Rhumatologie
& Symposium HPR
Theatersaal
UCB-Pharma
DUAL AF-ect - Cibler l'IL-17A/F pour un contrôle précis dans l'axSpA et la PsA
Traduction simultanée Allm.<>F
Navigating the tangled paths of axSpA: Can you steer the case with IL-17A/F?
Easing joint pain, clearing skin: Can IL-17A/F do it all in PsA?
Welcome
Expert deep dive: unraveling a complex case of axial Spondyloarthritis (axSpA)
Navigating the unknown: innovative strategies for managing axial PsA (axPsA)
AI in action: can technology help solve the complexity of Spondyloarthropathies?
Dynamic dialogue: interactive discussion and Q&A
Saal Brünig
Labatec
Theatersaal
Accueil et ouverture
Diana Dan, Andrea Rubbert-Roth
WIN Spondylarthrite axiale
WIN Syndrome des antiphospholipides
Theatersaal
Remise de Prix
Bourse de formation continue en recherche 2025
WIN Artérite à cellules géantes
Theatersaal
Prix de recherche Jean et Linette Warnery 2025
Remise des prix et présentation
Exposition
Pause de midi
Kongressssaal
Posterwalk I
P 1 - P 7
Tourguide: Judith Everts
P 1
MRI has limited accuracy in diagnosing Complex Regional Pain Syndrome Type 1 - a systematic review of the literature
Henzi A, Schneider S, Sutter R, Wertli M M, Brunner F; Zürich, Baden, Bern
P 2
Ultrasound assessment of the myotendinous junction of the long head of the biceps tendon for evaluating tendon integrity
Etter M, Schätz J, de Jong M, Scheibel M, Freislederer F, Diermayr S; Zürich, Winterthur, Davos
P 3
Ultrasound insights into enthesitis: discriminative value of inflammatory and structural lesions across the entheseal sites, comparing spondylarthritis patients to healthy individuals
Elsehrawy GG, Courvoisier DS, Deman E, Dan D, Micheroli R, Ziswiler H, Zufferey P, Brülhart-Bletsas L, Nissen MJ; Genève, Basel, Lausanne, Zürich, Bern, Fribourg, La Chaux-de-Fonds
P 4
First profiling of the swiss national SCQM Giant Cell Arteritis and Polymyalgia rheumatica registry
Stegert M, Brändli J, Blapp C, Mahr A, Iudici M, Tamborrini G, Christ L, Neumann T, Becker M, Berger C, Iking-Konert C, Scherer A, Villiger P, Daikeler T; Basel, Zürich, Genüve, Bern, St.Gallen
P 5
The Swiss Sjögren Cohort, a national collaborative project
Dumusc A, Sprecher M, Bannert B, Grosjean A, Kocher A, Lauper K, Klein K, Gadola S, Adler S, Ribi C, Kollert F, Christ L; Lausanne, Zürich, Basel, Vevey, Basel, Genève, Bern, Basel, Aarau
P 6
Osteoporosis treatment rates following hip, spine, and other fractures in older adults in Switzerland: Insights from National Health Claims Data (2021–2023)
Everts-Graber J, Schmid G, Häuselmann HJ, Huber C, Streit S, Ravensburger W, Reichenbach S, Pinedo-Villanueva R, Graber S; Bern, Luzern, Zürich, Oxford (UK)
P 7
Long-Term impact of Teriparatide on bone mineral density, trabecular bone score, and fracture risk relative to total hip T-score: A two-decade, registry-based cohort study
Guyer L, Lehmann O, Wenger M, Oser S, Studer U, Steiner C, Ziswiler R, Schmid G, Häuselmann HJ, Reichenbach S, Lehmann T, Everts-Graber J; Bern, Zürich, Luzern
P 8
Giant cell myocarditis and giant cell myositis with thymoma
Seitz P, Boscolo Berto M, Gasser M, Maurer B, Seitz L; Bern
P 9
Arthrite et tuberculose: il fallait y Poncet.
Colombo CE, Alromaih FJ, Alexe R, Argyriou P, Bisig B, Dumusc A, Dan D, Hügle T; Lausanne
P 10
A silent clue in the tendons: When tenosynovitis was just the beginning
Fedeli M, Garzoni C; Lugano
P 11
M. tuberculosis, der grosse Mimiker: eine mögliche Ursache von chronischer Monoarthritis und Daktylitis
Louppides S, Möller B, Manigold T; Bern
P 12
DRESSed like Still's disease: A case report of a pregnant patient with AOSD
Akyol O, Jörg L, Mosimann B, Bernsmeier C, Berger C, Daikeler T, Kyburz D, Kollert F; Basel, Bern
P 13
A case of tracheobronchopathia osteochondroplastica as a rare pulmonary manifestation of rheumatoid arthritis
Joos L, Rassouli F, Kellner J, Förger F, Rubbert-Roth A; St.Gallen
P 14
Features of IgG4-related disease in a patient with granulomatosis with polyangiitis
Kollert F, Bisharat DR, Hausenberger B, Negoias S, Heijnen I, Tzankov A, Kyburz D, Daikeler T; Basel
Theatersaal
Grand Debate
La thérapie par infiltration a-t-elle un rôle à jouer dans le traitement des douleurs lombaires ?
Pro: Stephan Gadola
Con: Stéphane Genevay
Modération: Lukas Wildi
Theatersaal
Fondation suisse pour la spondylarthrite ankylosante
Remise de prix de recherche 2025
Présentation 2023
The impact of a csDMARD in combination with a TNF inhibitor on drug retention and clinical remission in axial spondylarthritis
Michael Nissen
Nouvelle thérapie cellulaire et anticorps bispécifiques
Inhibiteurs JAK : réexamen
Club Casino
Joint Session SSR - HPR Switzerland
Innovations numériques en rhumatologie : bénéfices et limites de la e-santé
Modération: Diana Dan, Christel Madelaine-Bonjour
eHealth à l'hôpital – exemples et défis
Quelles applications recommander ? Comment évaluer leur qualité ?
Les défis éthiques de la numérisation dans le secteur de la santé : entre innovation et responsabilité
Discussion
Exposition
Pause
Theatersaal
IA en rhumatologie
Modération: Thomas Hügle
Sclérodermie (SSc) Mimics
Vascularites rares des petits vaisseaux
Jeûne, alimentation et microbiome dans les maladies rhumatismales
Microbiome et PR: Hype ou Hope?
Agenda:
- Diagnostic & monitoring role of CRP in rheumatic disease
- Prognostic role of CRP in rheumatic disease
- CRP beyond inflammatory arthritis
Speakers: William Tillett, Raphael Micheroli
Kongresssaal
Novartis Pharma Schweiz AG
Giant challenges, fresh thoughts: GCA & PMR by young rheumatologists
Chair: Andrea Rubbert-Roth
Speakers: Andrea Gloor, Camila Pitasi Arguelhes
Club Casino
GSK
Lupus & GEPA
Les voix des patient·e·s – Les pensées des experts
Apprendre ensemble – Agir ensemble
Chairs: C. Iking-Konert, Th. Neumann
traduction simultanée a↔f
Accueil
Les voix des patient·e·s
Des patientes témoignent de leur vie avec Lupus & GEPA
Patientes, Th. Neumann, C. Iking-Konert
Les pensées des experts
Où en sommes-nous dans la satisfaction des besoins de nos patient·e·s atteints de lupus ou de la GEPA?
Où et comment pouvons-nous nous améliorer?
Q&A, Take-aways
Theatersaal
CSL Vifor
Navigating complexity: Burden and evolving strategies in ANCA-associated vasculitis
Outcome measures in vasculitis
Advancing ANCA-vasculitis care: acting early to improve disease control
Kongresssaal
Abbvie
RheumARENA: A pro vs con debate on hot topics
Ulf Müller-Ladner, Lisa Christ, Ian Pirker
Chair: Andrea Rubbert-Roth
Simultanübersetzung D→F
Club Casino
Otsuka
«Targeting Metabolic Inflammation“ – Traitement moderne de l'obésité dans les maladies rhumatismales
Biologie du vieillissement et immunosenescence
Chaud et gras : le rôle de l'os sous-chondral dans l'arthrose
Mise à jour concernant la vaccination des patients sous immunosuppression
Covid et maladies auto-immunes : toujours d'actualité ?
L'inflammasome : comprendre son rôle pour mieux lutter contre les maladies inflammatoires
Theatersaal
AbbVie Rheumatology Fellowship Program 2025
Remise de prix
Kongresssaal
Pfizer Rheumatology Award 2024
Development of the first advanced course for patient research partners in rheumatology research in Switzerland
Muriel Elhai
Exposition
Pause
Ateliers
Difficult Cases
Sinnvolle Autoimmundiagnostik
Speicheldrüsenultraschall bei Sjögren-Syndrom
Manuelle Medizin - Untersuchung Halswirbelsäule
Médecine manuelle - Examen de la colonne cervicale
Imagerie de douleurs dorsales: inflammatoire ou mécanique?
Organisation und Strukturierung der Facharztpraxis
Research speed dating
Exposition
Pause de midi
P 15
Is there a diagnostic value of bedside labial salivary gland biopsy in patients with sicca syndrome?
Wolfrum S, Schmiedeberg K, Förger F, Rubbert-Roth A; St.Gallen, Bern
P 16
Prognostic value of systemic sclerosis-associated primary heart involvement
Gharibian C J, Lupi V, Gotschy A, Becker M O, Dobrota R, Elhai M, Muraru S, Jordan S, Hoffmann A M, Distler O, Manka R, Bruni C, Mihai C; Zürich, Oslo (N)
P 17
Predictors of long-term self-monitoring app use in inflammatory rheumatic diseases: Insights from the SCQM registry
Brändli J, Raptis C, Riek M, Grabowski A, Finckh A, von Mühlenen I, Roulin P, Möller B, Rubber-Roth A, Hügle T, Micheroli R; Zürich, Genève, Basel, Cham, Bern, St.Gallen, Lausanne
P 18
Association of chondrocalcinosis with disease activity and drug response in rheumatoid arthritis: baseline characteristics of the Swiss Rheumatoid Arthritis Outcomes cohort
Manigold T, Bodmer NS, Rosoux E, Fahrni G, Markham D, Micheroli R, Bachmann LM, Braendli J, Becce F, Hügle T; Bern, Zürich, Lausanne
P 19
Fear of progression in chronic rheumatological disorders: association with quality of life and perceived stress - an interim analysis
Sprau P, Christ L, Klein K, Borner U, Maurer B, Kollert F; Bern, Basel
P 20
Gaps in chronic and acute gout care: real-world data from an electronic health record-based register
Bürgisser N, Mongin D, Buclin C, Courvoisier DS, Lauper K; Genève
P 21
Ultrasonographic findings in patients with cystic fibrosis-associated arthropathy
Joos L, Haller C, Walter A, Brutsche M, Von Kempis J, Förger F, Schmiedeberg K; St.Gallen, Bern
Difficult Cases
Reasonable autoimmune diagnostics
Vaskulitis-Ultraschall bei GCA
Manuelle Medizin - Untersuchung Schultergürtel
Médecine manuelle - Examen de la ceinture scapulaire
Imaging of dorsal pain: inflammatory vs. mechanical?
Praxispersonal führen, fördern und fordern
OP 1
Precision-cut tissue slices from salivary glands (PCGS) – a potential ex vivo model for Sjögren’s disease
Roceri M, Guggisberg D, Seydoux E, Brunner M, Klein K; Bern
OP 2
Profiling synovial fibroblast morphological signatures for drug discovery
Laphanuwat P, Camarillo-Retamosa E, Seiler C, Ospelt C; Zürich, Maastricht (NL)
OP 3
Type I interferon signature negatively correlates with the expression of electron transport chain (ETC) components in mitochondria of peripheral blood B cells from patients with Sjögren’s Disease
Kakale A, Malkewitz SV, Duphey SM, Müller-Durovic B; Zürich
OP 4
Dysregulation of the Kynurenine pathway in rheumatoid arthritis: differential expression in circulating monocytes, joint macrophages, and serum
Malkewitz S, Duphey S, Makowiec C, Jäger J, Yang M, Khmelevskaia A, Lugar M, Frezza C, Kyburz D, Ospelt C, Distler O, Müller-Durovic B; Zürich, Basel, Köln (D)
OP 5
Transcriptomic and metabolomic profiling reveals upregulation of HIF1a–linked OXPHOS suppression, malic enzyme 3 (ME3) upregulation, and uric acid level changes in rheumatoid arthritis
Duphey S M, Malkewitz S, Kakale S, Hunter J, Makowiec C, Khmelevskaya A, Xenarios I, Lamachia C, Finckh A, Ospelt C, Müller-Durovic B; Zürich, Basel, Lausanne, Genève
OP 6
IVD Degradation-Driven Accumulation of Cytotoxic Vδ1 T-cells in Modic Type 1 Changes
Devan J, Heggli I, Mengis T, Sandalova M, Burri D, Herger N, Menghini D, Hatt P, Farshad M, Distler O, Dudli S; Zürich, New York (USA), Basel
Exposition
Pause
Kongresssaal
How I treat…dans des situations difficiles
Modération: Roxana Valcov, Katja Heinimann
Traitement antirhumatismal et l'ABC de l'hépatite
Traitement antirhumatismal et rein
Anti-rheumatic therapy in patients with malignant tumours
Récompense des meilleurs résumés
Modération: Andrea Rubbert-Roth
BA 1
Anti-Ro/SSA+/RF+ double seropositivity in SSc is associated with more severe SSc-ILD: a study from the EUSTAR database
Burja B, Boubaya M, Bruni C, E. Carreira P, Bergmann C, P. Ananyeva L, Riemerkasten G, Masado O, De Vries-Bouwstra J, Rosato E, Truchetet M, Del Papa N, Marcoccia A, Atzeni F, Schmeiser T, Vonk M, Del Galdo F, Distler O, Elhai M; Zürich, Bobigny (F), Madrid (E), Erlangen (D), Moscow (RUS), Lübeck (D), Tokyo (J), Leiden (NL), Rome (I), Bordeaux (F), Milano (I), Rome (I), Messina (I), Wuppertal-Elberfeld (D), Nijmegen (NL), Leeds (UK)
BA 2
Synovial fibroblasts, macrophages and dendritic cells form an inflammatory niche in rheumatoid arthritis, but not in psoriatic arthritis synovium.
Khmelevskaya A, Houtman M, Buerki K, Pauli C, Distler O, Ciurea A, Ramming A, Fearon U, Ospelt C, Micheroli R; Zürich, Erlangen (D), Dublin (IRL)
BA 3
Cancer incidence among rheumatoid arthritis patients treated with JAK-inhibitors compared to bDMARDs: data from an international collaboration of registers (the "JAK-pot" study)
Aymon R, Mongin D, Gilbert B, Guemara R, Choquette D, Codreanu C, Coupal L, Flouri I, Fritsch-Stork R, Giacomelli R, Huschek D, Iannone F, Kvien TK, Otero-Valera L, Nordström D, Pavelka K, Pombo-Suarez M, Provan SA, Rotar Z, Sidiropoulos P, Vieira-Sousa E; Genève, Montréal (CDN), Bucharest (RO), Crete (GR), Vienna (A), Berlin (D), Bari (I), Oslo (N), Madrid (E), Helsinki (FIN), Prague (CZ), Santiago de Compostela (E), Ljubjana (SLO), Heraklion (GR), Lisbon (P)
BC 1
VEXAS syndrome: successful treatment with allogeneic hematopoietic stem cell transplantation
Rubeli S, Merki R, Daikeler T, Halter J, Adler S; Aarau, Luzern, Basel
BC 2
Complement factor B inhibition as additional treatment option for Scleroderma renal crisis
Schmiedeberg K, Binet I, Rottländer Y, Ackermann C, Förger F, Rubbert-Roth A; St.Gallen, Bern
BC 3
Recurrent inflammation and impaired immune defense: the dual facets of a clinical enigma
Schläpfer-Pessina A, Dumusc A, Candotti F, Ribi C, Ammann S; Lausanne
BC 4
Opening the vasculitis barrel – a case report
Brennecke F, Rubeli S, Finkener S, Adler S; Aarau
BC 5
BiTE-ing refractory anti-synthetase syndrome
Rottländer Y, Launer H, Lehmann Th, Schmiedeberg K, Förger F, Rubbert-Roth A; St.Gallen, Bern
BC 6
Another chameleon: when symptoms mislead
Dudler M, Ahmanna Chakir F, Dudler J; Fribourg
Récompense du meilleur cas clinique
